Power Law company profile

Exelixis

Biotech & Life Sciences · San Francisco, United States · Founded 1994 · IPO 2000 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$10B

Market cap · Apr/2026

Revenue

$2.32B

Latest reported FY

Investors

10 investors on Exelixis's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 4 investors entered at this stage

PaineWebber

Atlas Venture

Stelios Papadopoulos

Oxford Bioscience Partners

Series A 4 investors entered at this stage

Domain Associates

Hambrecht & Quist Capital Management

Advent International

Pfizer

Series B+ 2 investors entered at this stage

University of California

Berkeley

Global footprint

Where Exelixis has talent and traffic

AI talent share

0.5% of workforce is AI talent
(7 of 1,521 staff)

Core AI20.13%

Other AI50.33%

Non-AI workforce1,51499.54%

Web traffic by country

36K monthly visits
across markets

🇺🇸 United States76.1%

🇮🇳 India11.7%

🇨🇦 Canada5.3%

🇬🇧 United Kingdom2.8%

🇩🇪 Germany1.7%

Top 5 markets shown

Patent intelligence

$161M patent portfolio · 108 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$161M

1.5% of market cap · 12.6× smaller than top peer Ablynx ($2B)

108 active patent families

Where Exelixis innovates Molecular biologyDiseasePharmaceutical medicineMedicinal chemistryPharmacology

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Exelixis on the five Patsnap quality dimensions

Exelixis in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Exelixis concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Exelixis and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Exelixis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo